The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Clearside Biomedical Inc shares valued at $24,910 were purchased by Chong Ngai Hang Victor on Jun 24 ’24. At $1.06 per share, Chong Ngai Hang Victor acquired 23,500 shares. The insider’s holdings grew to 63,500 shares worth approximately $83820.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, YERXA BENJAMIN R purchased 7,813 shares, netting a total of over 10,235 in proceeds. Following the buying of shares at $1.31 each, the insider now holds 17,957 shares.
Before that, Gibney Anthony S had added 93,290 shares to its account. In a trade valued at $121,277, the Director bought Clearside Biomedical Inc shares for $1.30 each. Upon closing the transaction, the insider’s holdings increased to 93,290 shares, worth approximately $0.13 million.
As published in their initiating research note from Chardan Capital Markets on August 21, 2024, Clearside Biomedical Inc [CLSD] has been a Buy and the price target has been revised to $6. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in late June. Earlier on July 29, 2021, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for CLSD stock.
Analyzing CLSD Stock Performance
During the last five days, there has been a drop of approximately -0.75%. Over the course of the year, Clearside Biomedical Inc shares have jumped approximately 12.82%. Shares of the company reached a 52-week high of $2.1200 on 03/12/24 and a 52-week low of $0.9200 on 09/05/24. A 50-day SMA is recorded $1.1509, while a 200-day SMA reached $1.2870. Nevertheless, trading volume fell to 1.66 million shares from 18.45 million shares the previous day.
Support And Resistance Levels for Clearside Biomedical Inc (CLSD)
According to the 24-hour chart, there is a support level at 1.2533, which, if violated, would cause prices to drop to 1.1867. In the upper region, resistance lies at 1.4133. The next price resistance is at 1.5067. RSI (Relative Strength Index) is 53.35 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0711, which suggests the price will decrease in the coming days. Percent R is at 58.93%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
